APA (7th ed.) Citation

Marco-Benedí, V., Sánchez-Hernández, R. M., Díaz, J. L., Jarauta, E., Suárez-Tembra, M., Pintó, X., . . . Civeira, F. (2024). PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention. Lipids in Health & Disease, 23(1), 1. https://doi.org/10.1186/s12944-024-02283-x

Chicago Style (17th ed.) Citation

Marco-Benedí, Victoria, et al. "PCSK9 Inhibitors on the Management of Primary and Secondary Cardiovascular Prevention." Lipids in Health & Disease 23, no. 1 (2024): 1. https://doi.org/10.1186/s12944-024-02283-x.

MLA (9th ed.) Citation

Marco-Benedí, Victoria, et al. "PCSK9 Inhibitors on the Management of Primary and Secondary Cardiovascular Prevention." Lipids in Health & Disease, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12944-024-02283-x.